(42 days)
The RS-1000 Zoom Slitlamp with option is intended for use in eye examination of the anterior eye segment, from the cornea epithelium to the posterior capsule. It is used to aid in the diagnosis of diseases or trauma which affect the structural properties of the anterior eye segment.
The RS-1000 Zoom slitlamp microscope consists of a microscope with a halogen lamp which illuminates the inner eye for examination with an optional attachment for photographic or video capabilities and an illumination power supply.
The provided documents describe a 510(k) premarket notification for the RS-1000 Zoom Slitlamp with option. This device is an AC-powered slitlamp biomicroscope intended for eye examination. The acceptance criteria and the study proving it meets these criteria are outlined in the "Performance testing" section.
Here's an analysis of the requested information:
1. A table of acceptance criteria and the reported device performance:
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Meet safety requirements of standard IEC 60601-1 | Met all safety requirements of IEC 60601-1 |
| Meet electromagnetic compatibility requirements of standard IEC 60601-1-2 | Met all electromagnetic compatibility requirements of IEC 60601-1-2 |
| Substantially equivalent to predicate devices with respect to intended uses, technological characteristics, and safety and effectiveness | Demonstrated equivalence to predicate devices (Marco Ophthalmic branded Ultra G5 zoom slitlamp, K930438) |
2. Sample size used for the test set and the data provenance:
The document describes performance testing in accordance with IEC standards, which typically involves testing of the device itself rather than a test set of patient data. Therefore, there is no sample size of patient data mentioned for a test set, nor any information about data provenance (country of origin, retrospective/prospective). The testing focused on the device's electrical, mechanical, and electromagnetic properties.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not applicable as the study did not involve establishing ground truth from patient data with expert readers. The testing was focused on engineering and performance standards for the medical device itself.
4. Adjudication method for the test set:
This information is not applicable as there was no test set involving human interpretation of medical images or data requiring adjudication.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:
No MRMC study was done, and therefore, no effect size of human reader improvement with AI assistance is mentioned. This device is a diagnostic illumination microscope and does not incorporate AI.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
This information is not applicable. The device is an optical instrument, not an algorithm.
7. The type of ground truth used:
The "ground truth" for this device's performance assessment appears to be the established technical and safety standards (IEC 60601-1 and IEC 60601-1-2) themselves. Compliance with these standards indicates the device performs as expected for its intended use. Equivalency to the predicate device also serves as a comparative "ground truth" for its clinical utility.
8. The sample size for the training set:
The document does not describe a "training set" in the context of machine learning or AI. The performance testing was on the manufactured device itself.
9. How the ground truth for the training set was established:
This information is not applicable as there was no training set in the context of machine learning or AI.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains a sequence of handwritten digits and a letter. The sequence starts with the letter 'K' followed by the numbers '060869'. The characters are written in a bold, dark ink, which contrasts with the white background. The handwriting style appears somewhat cursive, especially in the connection between the digits.
Image /page/0/Picture/1 description: The image shows the logo for RIGHTmedical. The logo has the word "RIGHTmedical" in bold, black letters. Below the word is the phone number 1-888-224 6012, followed by a black dot and the website address www.rightmedical.com. There are also some geometric shapes on the right side of the logo.
MAY 11 2006
200 Expressway Court Virginia Beach, Virginia 23462, USA
510(k) Summary
The information contained in this premarket notification 510(k) summary is submitted as required by 21 CFR 807.92(c):
| Submitter: | Right Medical Products LLC.200 Expressway Court,Virginia Beach, VA. USA23462 |
|---|---|
| Contact Person: | Harumi KumaharaRegulatory Affairs CoordinatorPhone: 416-398-3306 X244Fax: 416-631-8272hkumahara@rightmedical.com |
| Date Prepared: | February 2006 |
| Trade Name: | RS-1000 Zoom Slitlamp with option |
| Common Name: | AC-Powered Slitlamp Biomicroscope |
| Product Code: | HJO |
| Class: | Class II |
| Classification panel: | 86/ Ophthalmic |
| Predicate Device: | Substantial Equivalence is claimed based on theMarco Ophthalmic branded Ultra G5 zoom slitlamp(K930438), |
| Device Description: | The RS-1000 Zoom slitlamp microscope consists ofa microscope with a halogen lamp whichilluminates the inner eye for examination with an |
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the logo for Right Medical. The logo has the word "RIGHTmedical" in bold, black letters. Below the word is the phone number 1-888-224-6012 and the website www.rightmedical.com.
200 Expressway Court Virginia Beach, Virginia 23462, USA
optional attachment for photographic or video capabilities and an illumination power supply.
The RS-1000 Zoom slitlamp is a diagnostic Intended Uses: illumination microscope intended to examine the anterior eye segment, from the cornea epithelium to the posterior capsule. It is used to aid in the diagnosis of diseases or trauma which affects the structural properties of the anterior eve segment.
Technological Characteristics: The technological characteristics with option are the same or similar to those found with the predicate devices where the eye is examined by projecting light onto it.
Performance testing: The RS-1000 Zoom slitlamp was tested in accordance to IEC 60601-1 and IEC 60601-1-2 was found to meet all safety and electromagnetic compatibility requirements of the standards.
Conclusion: Based on non-clinical testing results, the RS-1000 Zoom slitlamp with option has demonstrated that it is equivalent to the predicate devices with respect to intended uses, technological characteristics and safety and effectiveness.
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized lines.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 1 1 2006
Right Medical Products, LLC. c/o Harumi Kumahara 200 Expressway Court Virginia Beach, VA 23462
Re: K060869
Trade/Device Name: RS-1000 Zoom Slitlamp with option Regulation Number: 21 CFR 886.1850 Regulation Name: AC-powered slitlamp biomicroscope Regulatory Class: Class II Product Code: HJO Dated: March 20, 2006 Received: March 30, 2006
Dear Ms. Kumahara:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
1f you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 827-8910. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
MB Eychhus MD
Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known): __
Device Name: RS-1000 Zoom Slitlamp with option
Indications for Use:
The RS-1000 Zoom Slitlamp with option is intended for use in eye examination of the anterior eye segment, from the cornea epithelium to the posterior capsule. It is used to aid in the diagnosis of diseases or trauma which affect the structural properties of the anterior eye segment.
Prescription Use V (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Denis L. McCarthy
(Division Sign-Off)
Division of Ophthalmic Ear,
Nose and Throat Devises
510(k) Number K060869
vii
§ 886.1850 AC-powered slitlamp biomicroscope.
(a)
Identification. An AC-powered slitlamp biomicroscope is an AC-powered device that is a microscope intended for use in eye examination that projects into a patient's eye through a control diaphragm a thin, intense beam of light.(b)
Classification. Class II (special controls). The device, when it is intended only for the visual examination of the anterior segment of the eye, is classified as Group 1 per FDA-recognized consensus standard ANSI Z80.36, does not provide any quantitative output, and is not intended for screening or automated diagnostic indications, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.